Journals / Bozok Tıp Dergisi / 2019 / Cilt: 9 - Sayı: 2

Retrospective Evaluation Of Operated Gynecological Malignancies Between 2009-2013 in Gaziosmanpaşa - Taksim Training And Research Hospital

2009-2013 YILLARI ARASINDA TAKSİM-GAZİOSMANPAŞA EĞİTİM VE ARAŞTIRMA HASTANESİNDE OPERE EDİLEN JİNEKOLOJİK MALİGNİTE VAKALARININ RETROSPEKTİF DEĞERLENDİRİLMESİ

Pages
58–66
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Keywords: Female genital neoplasms, endometrial neoplasms, ovarian neoplasms, uterin cervical neoplasms

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Evaluation of gynecological oncology cases performed in an educational research hospital in terms of sociodemographic characteristics Methods: In this retrospective study, the gynecological oncology cases performed between 2009 and 2013 were evaluated. 84 cases with complete hospital record information were included into the study.
📊
Key Findings & Data:Results: 46% of the cases were over, 30% were uterine corpus, 13,1% were cervix, 2,4% were vulva and 1,2% were vaginal cancer.
💡
Conclusion & Impact:Keywords: Female genital neoplasms, endometrial neoplasms, ovarian neoplasms, uterin cervical neoplasms
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Evaluation of gynecological oncology cases performed in an educational research hospital in terms of sociodemographic characteristics Methods: In this retrospective study, the gynecological oncology cases performed between 2009 and 2013 were evaluated. 84 cases with complete hospital record information were included into the study. The sociodemographic characteristics of the cases, the diagnoses, the operation performed, post-operative pathology reports, stage characteristics were used as data sources. Results: 46% of the cases were over, 30% were uterine corpus, 13,1% were cervix, 2,4% were vulva and 1,2% were vaginal cancer. Primary peritoneal carcinoma was detected in 1,2% of cases. Stage III-IV disease is 42% in over-cancer, 20% in endometrial cancer, and 9% in cervical cancer.The average age of all cases was 55,63 ± 13,72. The mean number of term births was 2,35 ± 2,08, the mean body mass index was 28,72 ± 2,55. More than half of the complaints of our gynecological cancer cases were pelvic pain and postmenopausal bleeding. Other complaints were irregular menstruation, abdominal swelling, vaginal discharge. Conclusion: Over cancer in our region is more common than other gynecological cancers. In addition, advanced disease is more common in over cancer. Pelvic pain, a non-specific symptom, is a common symptom in gynecologic cancers. It should be ensured that women do not neglect this symptom. Keywords: Female genital neoplasms, endometrial neoplasms, ovarian neoplasms, uterin cervical neoplasms

Özet

Amaç: İstanbul’da bir eğitim ve araştırma hastanesinde opere edilen jinekolojik kanser vakalarının sosyodemografik karakteristiklerinin ve sıklıklarının değerlendirilmesi. Gereç-Yöntem: Retrospektif düzenlenen bu çalışmada 2009-2013 yılları arasında opere edilen jinekolojik kanser vakaları değerlendirildi. Hastane kayıt bilgileri eksiksiz olan 84 vaka çalışmaya dahil edildi. Vakaların sosyo-demografik özellikleri, tanıları, yapılan ameliyat, ameliyat sonrası patoloji raporları, evre özellikleri çalışma veri kaynakları olarak kullanıldı. Bulgular: Vakaların %46’sı over, %30’u uterin korpus, %13,1’i serviks, %2,4’ü vulva ve %1,2’si vajen kanseridir. %1,2 vakada primer peritoneal karsinom mevcuttur. Evre III-IV hastalık over kanserlerinde %42, endometriyum kanserlerinde %20, serviks kanserinde %9’dur.Tüm vakaların yaş ortalaması 55,63 ± 13,72’dir. Ortalama term doğum sayısı 2,35 ± 2,08, vücut kitle indeks ortalması 28,72 ± 2,55’tir. Vakaların yarıdan fazlasında başvuru şikayeti pelvik ağrı ve postmenapozal kanamadır. Diğer başvuru şikayetleri düzensiz menstruasyon, abdominal şişkinlik ve vajinal akıntıdır. Sonuç: Bölgemizde over kanseri diğer jinekolojik kanserlerden daha sıktır. Ek olarak ileri evre hastalık, over kanserlerinde daha sık olarak görülmektedir. Non-spesifik belirti olan pelvik ağrı jinekolojik kanserlerde sık rastlanan bir semptomdur. Kadınların bu belirtiyi ihmal etmemelerinin sağlanması önemlidir. Anahtar Sözcükler: Kadın genital tümörleri, ednometriyal neoplaziler, ovaryen neoplaziler, uterin servikal neoplaziler

🔖

Cite This Article

GENCER, F. K. (2022). Retrospective Evaluation Of Operated Gynecological Malignancies Between 2009-2013 in Gaziosmanpaşa - Taksim Training And Research Hospital. Bozok Tıp Dergisi, Cilt: 9 - Sayı: 2, 58–66. https://ajindex.com/articles/468563

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Global Burden of Disease Cancer Collaboration. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016:A Systematic Analysis for the Global Burden of Disease Study. JAMAOncology June 2,2018. doi:10.1001/ jamaoncol. 2018.2706
  2. Gultekin M, Dundar S, Kucukyildiz I, Karaca MZ, Boztas G, Turan SH, et al. Survival of gynecological cancers in Turkey: where are we at?J Gynecol Oncol. 2017;28(6):e85
  3. Pınar I, Algıer L, Doğan N, Kaya N. Determination of the Risk Factors in Individuals with Gynecological Cancer. Int J Hematol Oncol Stem Cell Res. 2008;(4):208-16
  4. Lyngea E, Lönnbergb S, Törnberg S. Cervical cancer incidence in elderly women-biology or screening history?Eur J Cancer. 2017;(74):82-8
  5. Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, et al. Human papillomavirus–associated cancersUnited States, 2008–2012. MMWR Morb Mortal Wkly Rep. 2016;65(26):661-6
  6. Purdie DM, and GreenAC.Best Pract Res Clin Obstet Gynaecol;15(3):341-54
  7. Kheiri SA, Kunna A, Babiker AY, Alsuhaibani SA, Ahmed RY, Alsammani MA. Histopathological Pattern and Age Distribution of Malignant Ovarian Tumor among Sudanese Ladies. Maced J Med Sci. 2018;12;6(2):237-41
  8. Adegoke O,. KulasingamS, and VirnigB. Cervical cancer trends in the United States: a 35‐year population‐based analysis. J. Womens Health. 2012;(21):1031–7
  9. Eifel PJ, BurkeTW, MorrisM, and SmithTL. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma. Gynecol. Oncol1995;(59):38–44
  10. Bray FB, Carstensen H, Møller H, ZappaM, ZakeljMP, LawrenceG, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol. Biomarkers Prev. 2005;(14):2191-9
  11. Smith HO, TiffanyMF, QuallsCR, and KeyCR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States–a 24‐year population‐based study. Gynecol. Oncol. 2000;(78):97–105
  12. Visioli CB, ZappaM, CiattoS, IossaA, and CrocettiE. Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985‐2000. Cancer Detect. Prev 2004;(28):461-4
  13. Oh CM, JungKW, WonYJ, ShinA, KongHJ, JunJK, et al. Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009. PLoS ONE. 2013;